Global Expert Perspectives on Treatment Strategies in Neuroendocrine Tumors

Global Expert Perspectives on Treatment Strategies in Neuroendocrine Tumors

Episodes

Specialty:

All

Year:

All

EP. 1: The Underlying Biology and Prevalence of NETs

January 7th 2019

EP. 2: Accurately Diagnosing NETs

January 7th 2019

EP. 3: Classifying and Treating NETs

January 7th 2019

EP. 4: Recognizing the Symptoms of NETs

January 7th 2019

EP. 5: Therapies for Controlling Symptoms of NETs

January 7th 2019

EP. 6: Surgical Considerations for Patients With NETs

January 7th 2019

EP. 7: Somatostatin Analogs in the Treatment of NETs

January 7th 2019

EP. 8: Targeted Therapies for the Treatment of NETs

January 7th 2019

EP. 9: Peptide Receptor Radionuclide Therapy for NETs

January 7th 2019

EP. 10: Somatostatin Analogs and PRRT: Treatment Considerations

January 7th 2019

EP. 11: Chemotherapy for NETs: Temozolomide

January 7th 2019

EP. 12: Novel Therapies Emerging for the Treatment of NETs

January 7th 2019

EP. 13: Future Outlook: Improving the Management of NETs

January 7th 2019

Trending on OncLive

Dostarlimab Monotherapy Elicits Durable cCRs in dMMR/MSI-H Locally Advanced Rectal Cancer

NEXERA-303 Trial Aims to Bring TGFβR2×PD-1 Bispecific Antibody INCA33890 Into First-Line MSS CRC

NCCN Guideline Inclusion Broadens Access to Brigatinib in NF2-Related Schwannomatosis

The OncFive: Top Oncology Articles for the Week of 10/25

INCB161734 Combination Data Shape DAWN-303’s All-Comers Design in Frontline KRAS G12D-Mutated PDAC